News for 'pharmaceutical industry'

'We are looking at flying an Indian into space'

'We are looking at flying an Indian into space'

Rediff.com8 Dec 2023

'It's vital that over the next 10 years, that India, the US and the Artemis Accords family of nations come together to ensure that we not only return humanity to the moon, but that we build the technology that will allow us stay there permanently.' 'And then go on to Mars.'

Why India Inc is moving to Dubai in droves

Why India Inc is moving to Dubai in droves

Rediff.com7 Nov 2022

Reliance Industries chairman Mukesh Ambani might have made news for purchasing the most expensive beach-side villa in Dubai recently, but he is not the only Indian eyeing the city for investment. Since Dubai allowed foreign investors full ownership in specific sectors in June 2021, a horde of Indian companies have moved or expanded into the desert city. The list even includes a kindergarten, an elementary and middle school, and a hotel that has sought 100 per cent ownership.

Modi govt plans to make medicines cheaper

Modi govt plans to make medicines cheaper

Rediff.com24 Jun 2014

The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.

Meet the man behind the Sun Pharma-Ranbaxy deal

Meet the man behind the Sun Pharma-Ranbaxy deal

Rediff.com8 Apr 2014

Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.

Pfizer set to buy Allergan for more than $150 bn

Pfizer set to buy Allergan for more than $150 bn

Rediff.com23 Nov 2015

The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.

India, US officials to meet after Budget to discuss investment

India, US officials to meet after Budget to discuss investment

Rediff.com27 Jan 2015

Senior officials of India and the US will meet after the forthcoming Budget session to identify and prioritise sectors for investments and technology sharing.

Daiichi Sankyo to offload stake in Sun Pharma

Daiichi Sankyo to offload stake in Sun Pharma

Rediff.com20 Apr 2015

Daiichi won't remain a major shareholder in Sun Pharma.

MFN status must for India: Pakistani industry chamber

MFN status must for India: Pakistani industry chamber

Rediff.com15 Nov 2013

Federation of Pakistan Chambers of Commerce and Industry President Zubair Ahmed Malik also said that the negative list should also be pruned to boost bilateral trade with India.

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin recalls 9,210 bottles of anti-infective drug from the US

Rediff.com15 Apr 2014

The recent recalls come amid increased FDA scrutiny of medicines produced in India.

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Sensex closes 415 points higher; crosses 60K

Sensex closes 415 points higher; crosses 60K

Rediff.com6 Mar 2023

Among Sensex stocks, Tata Motors rose the most by 2.79 per cent. NTPC, Reliance Industries, Infosys, TCS, HDFC twins, Tata Motors, ITC, Power Grid and Bajaj Finserv were among the major gainers. Tata Steel fell the most by 1.22 per cent. L&T, Sun Pharmaceuticals, IndusInd Bank and Ultratech Cement were among the losers.

Is The Rally In Small And Microcap Stocks Sustainable?

Is The Rally In Small And Microcap Stocks Sustainable?

Rediff.com28 Sep 2023

While the corporate sector has benefited from massive capital expenditure, leading to sky-rocketing stock prices, investors would do well to keep an eye on the macroeconomic picture and government finances, not just corporate profits, for signs of trouble, alerts Debashis Basu.

India Inc may see over 22% profit jump in Q1; revenue growth may disappoint

India Inc may see over 22% profit jump in Q1; revenue growth may disappoint

Rediff.com17 Jul 2023

Brokerages expect Nifty50 companies to have cumulatively witnessed strong double-digit growth in their earnings in the first quarter of FY24 (Q1FY24). This growth in the combined earnings is expected to have been driven by banks, automakers, and oil & gas companies. Other sectors may report muted profit growth.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

Reliance Takes Another Bite At Dairy

Reliance Takes Another Bite At Dairy

Rediff.com18 Apr 2023

This is the Mukesh Ambani-led company's second entry into the dairy segment and it will directly compete with Amul and Mother Dairy.

Pharma M&As to drive Infosys' life sciences biz

Pharma M&As to drive Infosys' life sciences biz

Rediff.com5 Jun 2014

Launches cloud-based version of solution to target mid-size clients in life sciences.

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Rediff.com12 Sep 2014

Sun Pharma stated the company wanted shareholders' approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP."

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

Dhirubhai Ambani, Dilip Shanghvi chosen for Padma awards

Dhirubhai Ambani, Dilip Shanghvi chosen for Padma awards

Rediff.com25 Jan 2016

Dhirubhai Ambani lived in a one-room chawl in Mumbai with his wife and children and went on to establish the Reliance Group.

India must act fast to frame new IPR policy

India must act fast to frame new IPR policy

Rediff.com24 Nov 2014

India had been engaged in a contentious battle with the US over the issue, especially in the pharmaceutical sector.

Factors that will sustain Abbott outperformance

Factors that will sustain Abbott outperformance

Rediff.com22 Mar 2023

Abbott India outperformed the Indian pharmaceutical market (IPM) with a year-on-year (YoY) growth of 23 per cent in February. The domestic market grew at a robust 20 per cent on a low base, primarily led by volume growth and price hikes. Abbott continued to outperform the sector in the anti-diabetic space with a growth of 20 per cent and key brands such as Thyronorm (hypothyroidism), biliary agent Udiliv, insulin Ryzodeg posted robust growth.

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Rediff.com27 Sep 2022

The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).

Centre seeks info from embassy on Iran's bar on rice, tea imports

Centre seeks info from embassy on Iran's bar on rice, tea imports

Rediff.com8 Dec 2022

The department of commerce has urged the agriculture ministry as well as the diplomatic mission in Tehran to apprise it of details as to why Iranian buyers have stopped import of rice and tea from India, a senior government official said. Exporters said that exports of items such as high quality tea and rice have stopped since last week. As of now, there has been no confirmation from the authorities and the response from the embassy in Tehran is also taking time, they said.

Managers for the pharma industry

Managers for the pharma industry

Rediff.com11 Jan 2005

The SIES College of Management Studies invites applications for two of its flagship programmes.

Smaller pharma contract producers face closure

Smaller pharma contract producers face closure

Rediff.com8 Apr 2014

The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.

In China, Modi to push for expediting industrial parks

In China, Modi to push for expediting industrial parks

Rediff.com12 May 2015

Beijing wants assurance that its investments won't come under scrutiny

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Rediff.com9 Apr 2014

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments

'Investors should stay invested'

'Investors should stay invested'

Rediff.com14 Jul 2023

'Markets are not expensive; they are fairly priced.'

PIX: Gadkari rides to Parliament in hydrogen-powered car

PIX: Gadkari rides to Parliament in hydrogen-powered car

Rediff.com30 Mar 2022

India will soon become a green hydrogen exporting country, the road transport and highways minister told reporters before leaving for Parliament in the car, which is the first of its kind in India.

Barsu refinery: People must be taken into confidence, says Uddhav

Barsu refinery: People must be taken into confidence, says Uddhav

Rediff.com28 Apr 2023

Thackeray, whose Maha Vikas Aghadi government fell after a rebellion in June last year by his cabinet colleague Eknath Shinde, who went on to become CM, also warned he would extract revenge for his ouster.

Ministries clash over cap on foreign stakes in drug firms

Ministries clash over cap on foreign stakes in drug firms

Rediff.com28 Nov 2013

The finance ministry is resisting pressure from other departments to cap foreign ownership of domestic drugmakers, fearing such a move would discourage potential investors, a senior ministry source said.

GST Council likely to meet early Jan; may discuss rate rationalisation

GST Council likely to meet early Jan; may discuss rate rationalisation

Rediff.com20 Dec 2021

The Centre is looking to convene a meeting of the all-powerful Goods and Service Tax Council in early January. The meeting is likely to focus on rectifying the inverted duty structure for a few more items and will also serve as a platform for pre-Budget discussions between Union Finance Minister Nirmala Sitharaman and state finance ministers, Business Standard has learnt. "The current Winter Session of Parliament ends on December 23, followed by the Christmas-New Year period. "After that we would like to have a meeting of the GST Council, depending on whether there can be a quorum," a top government official said.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Major General S C N Jatar: An Unsung Hero

Major General S C N Jatar: An Unsung Hero

Rediff.com25 Oct 2023

Major General S C N Jatar, who passed into the ages on Monday night, thwarted anti-national forces at the peak of the Assam agitation. Colonel Anil A Athale (retd) salutes this officer and gentleman.

Merger woes: Sun Pharma asks some Ranbaxy staff to leave

Merger woes: Sun Pharma asks some Ranbaxy staff to leave

Rediff.com18 Jun 2015

Nearly 150 senior management staff will be asked to leave.

'It is difficult for us to get rid of China overnight'

'It is difficult for us to get rid of China overnight'

Rediff.com6 Jul 2020

'China feels India will be hard-pressed not to go after China because we are so badly dependent on them -- and that is the reality.'

Urge states to use lockdown as last resort, PM Modi tells nation

Urge states to use lockdown as last resort, PM Modi tells nation

Rediff.com20 Apr 2021

The two key messages of Modi's over 20 minute-long address was, however, to virtually rule out any immediate nationwide lockdown, a move that had triggered a massive migration of workers from big cities last year and hit the economy hard, and to reach out to migrants.

VAT uncertainty hits industry hard

VAT uncertainty hits industry hard

Rediff.com9 Apr 2003

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Covid-19 leads to India's only quinine factory being revived

Covid-19 leads to India's only quinine factory being revived

Rediff.com17 Apr 2020

Perched in the hills of Darjeeling, the factory was set up in 1874, but has remained shut since 2001. Efforts to reopen the colonial era establishment are now on a war footing.